U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 15

TABLE OF CONTENTS
9
U . S . IN VITRO DIAGNOSTICS MARKET , BY END USER ............................................................. 74
• 9.1
INTRODUCTION ............................................................................................................................................................... 75
• 9.2
HOSPITAL LABORATORIES .............................................................................................................................................. 76
• 9.3
CLINICAL / INDEPENDENT LABORATORIES ...................................................................................................................... 77
• 9.3.1
LARGE LABORATORIES / REFERENCE LABORATORIES ................................................................................... 80
• 9.3.2
MEDIUM-SIZED LABORATORIES ................................................................................................................... 80
• 9.3.3
SMALL LABORATORIES ................................................................................................................................. 80
• 9.4
OTHER END USERS .......................................................................................................................................................... 81
10
COMPETITIVE LANDSCAPE ....................................................................................................... 83
• 10.1
OVERVIEW ........................................................................................................................................................................ 83
• 10.2
MARKET SHARE ANALYSIS ............................................................................................................................................. 85
• 10.3
COMPETITIVE SITUATION AND TRENDS ......................................................................................................................... 87
• 10.3.1
NEW PRODUCT LAUNCHES .......................................................................................................................... 87
• 10.3.2
COLLABORATIONS , AGREEMENTS , & PARTNERSHIPS ................................................................................ 88
• 10.3.3
APPROVALS ................................................................................................................................................... 89
• 10.3.4
MERGERS & ACQUISITIONS ......................................................................................................................... 90
• 10.3.5
OTHERS ......................................................................................................................................................... 91
11
COMPANY PROFILES ................................................................................................................. 92
• ( Overview , Financials , Products & Services , Strategy , & Developments )*
• 11.1
ABBOTT LABORATORIES , INC .......................................................................................................................................... 93
• 11.2
DANAHER CORPORATION ................................................................................................................................................ 97
• 11.3
JOHNSON AND JOHNSON ............................................................................................................................................. 103
• 11.4
ROCHE DIAGNOSTICS ................................................................................................................................................... 106
• 11.5
SIEMENS HEALTHCARE ................................................................................................................................................. 112
• 11.6
BECTON , DICKINSON AND COMPANY .......................................................................................................................... 118
• 11.7
BIOMÉRIEUX .................................................................................................................................................................. 123
• 11.8
BIO-RAD LABORATORIES , INC ....................................................................................................................................... 128
• 11.9
SYSMEX CORPORATION ................................................................................................................................................ 133
• 11.10
THERMO FISHER SCIENTIFIC , INC ................................................................................................................................ 139
• 11.11
QIAGEN N . V .................................................................................................................................................................... 145
• * Details on Financials , Product & Services , Strategy , & Developments might not be captured in case of unlisted companies .
sales @ marketsandmarkets . com www . marketsandmarkets . com
15